CD8A and neoplasm: What is more, blocking B7-H3 with mAbs has not only demonstrated enhanced infiltration of CD8+ T cells and NK cells into tumors but has also led to diminished tumor growth and, most importantly, extended survival in murine models, offering a ray of hope for cancer treatment outcomes [29,216,217].